Keith Goldan

Keith Goldan

Director of Finance/CFO chez SYNDAX PHARMACEUTICALS, INC.

Fortune : 1 M $ au 31/03/2024

52 ans
Health Technology
Consumer Services
Retail Trade

Profil

Keith Alan Goldan is the founder of Century Capital Associates.
He is currently the Treasurer, Chief Financial & Accounting Officer at Syndax Pharmaceuticals, Inc. (since 2023).
Previously, he held the position of Chief Financial Officer & Director at Realm Therapeutics Plc (2004-2008), CFO, Treasurer & Senior Vice President at Fibrocell Science, Inc. (2015-2017), Chief Financial Officer & Senior Vice President at NuPathe, Inc. (2013-2014), and Chief Financial Officer at OptiNose, Inc. (2017-2022).
He also served as the Chief Financial Officer & Vice President at Biosyn, Inc. and Chief Financial Officer at Cantel Medical (UK) Ltd.
Mr. Goldan obtained an undergraduate degree from the Robert H.
Smith School of Business and an MBA from The Wharton School of the University of Pennsylvania.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
08/03/2024 51 373 ( 0,06% ) 1 M $ 31/03/2024

Postes actifs de Keith Goldan

SociétésPosteDébut
SYNDAX PHARMACEUTICALS, INC. Director of Finance/CFO 13/06/2022
Tous les postes actifs de Keith Goldan

Anciens postes connus de Keith Goldan

SociétésPosteFin
OPTINOSE, INC. Director of Finance/CFO 10/06/2022
FIBROCELL SCIENCE, INC. Director of Finance/CFO 01/01/2017
NUPATHE INC Director of Finance/CFO 21/02/2014
Director of Finance/CFO 31/10/2008
REALM THERAPEUTICS PLC Director of Finance/CFO 13/10/2008
Voir l'expérience en détail de Keith Goldan

Formation de Keith Goldan

Robert H. Smith School of Business Undergraduate Degree
The Wharton School of the University of Pennsylvania Masters Business Admin

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Keith Goldan

Relations

82

Relations au 1er degré

10

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Sociétés cotées2
SYNDAX PHARMACEUTICALS, INC.

Health Technology

OPTINOSE, INC.

Health Technology

Entreprise privées6

Health Technology

Health Technology

Health Technology

Health Technology

Retail Trade

Century Capital Associates

Voir les connexions sociétés
  1. Bourse
  2. Insiders
  3. Keith Goldan